References
1. Álvarez-Blasco F, et al. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of Internal Medicine 2006; 166:2081-86.
2. Azziz R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004; 89:2745-49.
3. Teede, et al. CHECK Program: Polycystic ovary syndrome. The Royal Australian College of General Practitioners, Melbourne, 2008.
4. Ferriman D, Gallwey J. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961; 21:1440-47.
5. Legro RS, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 1999; 84:165-69.
6. Boomsma CM, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update 2006: http://humupd.oxfordjournals.org/cgi/content/abstract/12/6/673
7. Norman RJ, et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or noninsulin dependent diabetes mellitus in polycystic ovarian syndrome. Human Reproduction 2001; 16:1995-98.
8. Meyer C, et al. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
Diabetes Care 2007; 30:471-78.
9. Salley et al. Position Statement: Glucose Intolerance in PCOS. J. Clinical Endocrinology and Metabolism, 2007; 92:4546-56.
Resources for consumers and/or health professionals
This article first appeared in Australian Doctor, How to treat on 29 August 2008 and has been reproduced here with permission.
Australian Doctor, How to treat: Polycystic ovary syndrome 437.44 Kb
Content updated 20 November, 2009
|